Advancement and Tribulations in Ocular Drug Delivery

Vivek Dave, Swapnil Sharma, Sachdev Yadav, Sarvesh Paliwal


Development of new drug candidates and novel delivery techniques for treatment of ocular diseases has recently accelerated. The field of ocular drug delivery is one of the most interesting and challenging endeavors facing the pharmaceutical scientist for past 10-20 years. In ophthalmic formulation to the eye like solutions, suspensions, and ointments are available in the market shows drawbacks such as increased precorneal elimination, blurred vision and high variability in efficiency. The major setback associated with the conventional dosage forms is the bioavailability of drug. In the last three decades to improve the bioavailability by common to adding viscosity-enhancing agents or mucoadhesive polymers into dosage formulations. To prevail over to conventional dosage formulations there were non-conventional technologies such as lipososme, niosome, microspheres, nanoparticle, implant, gene therapy and ocular inserts could be developed in pharmaceutical market. In this article, we have summarized the different types of commonly used ophthalmic formulations and compared the conventional formulations with the advanced formulation in many respects like their applicability, acceptance, characteristics and utility.

Ocular drug delivery is one of the most interesting and challenging endeavours facing the

pharmaceutical scientist...The anatomy, physiology and biochemistry of the eye render this organ exquisitely impervious to foreign substances...The challenge to the formulator is to outwit the protective barriers of the eye without causing permanent tissue damage...The ancient ophthalmic solutions, suspensions and ointment dosage forms are clearly no longer sufficient to combat some present virulent diseases...”


Lipososme, Niosome, Microspheres, Implant, Gene Therapy and Ocular Inserts

Full Text:



Clark AF, Yorio T. Nat Rev Drug Discov. by Macmillan Publishers ; 2003; 2, 448-592.

Macha S, Mitra AK. Ophthalmic drug delivery systems; second edition revised and expanded. Chapter 1 Overview of Ocular Drug Delivery. 1998; 1-3.

Mundada AS, Avari JG, Mehta SP, Pandit SS, Patil AT. Recent advances in ophthalmic drug delivery system. Pharm Rev; 2008; 6(1), 24-26.


  • There are currently no refbacks.

Copyright (c)

               AR Journals

18K, Street 1st, Gaytri Vihar, Pinto Park, Gwalior, M.P. India (Design) 2009-2021


Follow @arjournals on Twitter